As NCI Sets Deadline For B-06 Reanalysis, Fisher Lawyer Says Demand Is Illegal
In Brief: Coalition Begins Campaign To Educate Public
About Need For Cancer Research Funding
NCI Okays Agreement Between Allegheny, Pitt, Over NSABP
NCI Drug Development Program Produced 7 Drugs In 10 Years, Chabner Tells Group
Letters: Subcommittee Report Full Of Errors, Gallo Attorney Says
OSI Underestimated Magnitude Of Gallo Case: Hadley
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Anthony Letai pledges to ensure stability for extramural and intramural cancer science









